TY - JOUR
T1 - High-dose procainamide in chronic renal failure
AU - Bottorff, M. B.
AU - Kuo, C. S.
AU - Batenhorst, R. L.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 1983
Y1 - 1983
N2 - A patient with chronic renal failure who experienced symptomatic ventricular tachycardia was treated successfully with procainamide (PA) after numerous dosage adjustments to optimize his clinical response and serum PA and NAPA concentrations. Efforts to maintain total combined serum levels at 20-30 μg/ml led to sustained ventricular ectopy whenever the serum PA levels decreased to < 8 μg/ml.
AB - A patient with chronic renal failure who experienced symptomatic ventricular tachycardia was treated successfully with procainamide (PA) after numerous dosage adjustments to optimize his clinical response and serum PA and NAPA concentrations. Efforts to maintain total combined serum levels at 20-30 μg/ml led to sustained ventricular ectopy whenever the serum PA levels decreased to < 8 μg/ml.
UR - http://www.scopus.com/inward/record.url?scp=0020576994&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020576994&partnerID=8YFLogxK
U2 - 10.1177/106002808301700408
DO - 10.1177/106002808301700408
M3 - Article
C2 - 6839958
AN - SCOPUS:0020576994
SN - 0012-6578
VL - 17
SP - 279
EP - 281
JO - Drug Intelligence and Clinical Pharmacy
JF - Drug Intelligence and Clinical Pharmacy
IS - 4
ER -